Form 8-K - Current report:
SEC Accession No. 0001628280-24-051374
Filing Date
2024-12-16
Accepted
2024-12-16 16:00:17
Documents
13
Period of Report
2024-12-13
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 8-K cdxc-20241213.htm   iXBRL 8-K 20433
  Complete submission text file 0001628280-24-051374.txt   142128

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdxc-20241213.xsd EX-101.SCH 1776
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdxc-20241213_lab.xml EX-101.LAB 21689
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdxc-20241213_pre.xml EX-101.PRE 12519
15 EXTRACTED XBRL INSTANCE DOCUMENT cdxc-20241213_htm.xml XML 2733
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 241551732
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)